-
Mashup Score: 0Programme - HRC2023 - Heart Rhythm Congress - 8 month(s) ago
Programme. Discussion, debate, diversity, innovation and review – HRC, the word in education in arrhythmias.
Source: www.heartrhythmcongress.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1DOACs for stroke prevention safe in most high-risk populations with AF - 10 month(s) ago
PHILADELPHIA — Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation are safe in most high-risk populations, a speaker said during the Heart in Diabetes CME Conference.Meta-analyses have shown that direct oral anticoagulants (DOACs) are better than vitamin K antagonists such as warfarin for prevention of stroke and systemic embolism, and trend toward being
Source: www.healio.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#DOACs for #stroke prevention in patients with #AFib appear safe in most high-risk populations research suggests per @GoHealio: https://t.co/2uPZX5BCF2
-
-
Mashup Score: 6Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation—a call for A-C-T-I-O-N - 11 month(s) ago
This editorial refers to ‘Outcomes of patients with atrial fibrillation and ischaemic stroke while on oral anticoagulation’, by A. P. Benz et al., https://doi.o
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
Ischaemic stroke in atrial fibrillation patients while on oral anticoagulation: a call for A-C-T-I-O-N. Read more in #EHJ: https://t.co/9bAo7pTyix #AF #stroke #anticoagulation #OAC #VKA #DOACS #cardiotwitter @escardio @ESC_Journals https://t.co/CuscgJ03wB
-
-
Mashup Score: 0Standard-Dose DOAC Better for Kidney-Impaired Patients - 1 year(s) ago
Meta-analysis of patient-level trial data argues against common underdosing strategy
Source: www.medpagetoday.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#DOACs safely bested both lower doses and warfarin among patients with #kidneydysfunction in subgroup analysis across pivotal clinical trials in #AF. #MedTwitter https://t.co/m5orKVCJDQ
-
-
Mashup Score: 0DOAC Study Finds Increased Myocardial Infarction Risk for Dabigatran | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination February 1, 2023 Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. There are no randomized clinical trial results comparing the relative safety and efficacy of…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Among patients with #atrial #fibrillation taking #DOACS, #rivaroxaban was found to be associated with higher major bleeding rates, while #dabigatran was associated with twofold higher rates of #myocardial #infarction https://t.co/YfOtN9QdK4
-
-
Mashup Score: 55Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - 1 year(s) ago
Abstract Background The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome remain controversial. Objectives The authors performed a sys…
Categories: Expert Picks, Latest HeadlinesTweet-
In this meta-analysis of #RCTs of patients with thrombotic #antiphospholipid syndrome, treatment with #DOACs had a higher risk of arterial thrombosis than #VKAs. https://t.co/DlOMgJ9g84 #JACC #VTE #cvVTE #CardioTwitter https://t.co/b7DjwEmhMT
-
-
Mashup Score: 0Anticoagulant Therapy for Cancer-Associated Thrombosis: A Cost-Effectiveness Analysis: Annals of Internal Medicine: Vol 0, No 0 - 1 year(s) ago
Background: Direct oral anticoagulants (DOACs) offer an alternative to low-molecular-weight heparin (LMWH) and warfarin for treating cancer-associated thrombosis (CAT). Objective: To determine the cost and effectiveness of DOACs versus LMWH. Design: Cohort-state transition decision analytic model. Data Sources: Network meta-analysis comparing DOACs versus LMWH. Target Population: Adult patients…
Source: Annals of Internal MedicineCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
An analysis comparing #DOACs to LMWH found DOACs are both more medically effective & cost-effective when treating cancer-associated #thrombosis. Findings may inform clinical and policy decisions: https://t.co/D1ozhF4AxU https://t.co/qYdx0XcK8J
-
-
Mashup Score: 2
While overall gastrointestinal bleeding (GIB) rates have been extensively compared between warfarin and direct oral anticoagulants (DOACs), it is still unclear whether upper and lower GIB rates differ between these types of drugs. This study aimed to compare upper and lower GIB rates between warfarin and DOACs in a nationwide cohort.
Categories: Latest Headlines, NeurologyTweet-
Via @AGA_CGH: #Warfarin was linked with higher rates of upper #gastrointestinal bleeding than direct oral anticoagulants (#DOACs): https://t.co/7FbriwDBum @AmerGastroAssn @AANMember #neurotwitter https://t.co/uFpDPPSPyD
-
-
Mashup Score: 0ACP Gastroenterology Monthly - 2 year(s) ago
ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
Source: gastroenterology.acponline.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The latest in ACP #Gastroenterology Monthly: https://t.co/tGaBCShDNN 🔸 GI bleeding risks with #warfarin and #DOACs compared 🔸 #Heartfailure risk increased in patients with #NAFLD, meta-analysis finds 🔸 #HCV treatment effective, but underutilized, studies show https://t.co/1rYHrN326H
-
-
Mashup Score: 0CVS Caremark to Reverse Change to DOAC Formulary Classification - American College of Cardiology - 2 year(s) ago
CVS Caremark has informed the ACC that due to a significant reduction in manufacturer pricing the pharmacy benefits manager will return to apixaban as a preferred product over other direct oral anticoagulants (DOACs) effective July 1. Since January 2022, CVS Caremark has required patients on apixaban to switch to rivaroxaban or request a formulary exception. As of July 1, these patients will…
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
CVS Caremark has informed the ACC that due to a significant reduction in manufacturer pricing the pharmacy benefits manager will return to apixaban as a preferred product over other #DOACs effective July 1. Learn more: https://t.co/tUn0EKWqQv #ACCAdvocacy #cvCoag #NOAC
-
What's new with #AF? Is the future of #DOACs bright? Find out on 08 Oct at the AF symposia: https://t.co/cQtibKFWHF What? Why? Does? Will? We have all the answers from world experts including Professor John Camm. Register NOW: https://t.co/zphlLyCSQQ https://t.co/4uP7xfAfYk